affiliation not provided to SSRN
chronic kidney disease, advanced kidney disease, cardiovascular diseases, hyperuricemia, febuxostat, allopurinol, and xanthine oxidase inhibitors
Type 2 diabetes, glucagon-like peptide-1 receptor agonists, dipeptidyl peptidase-4 inhibitors, real-world data, bone fracture, target trial emulation